Oct 30- Vertex Pharmaceuticals Inc said it received a subpoena from the U.S. Department of Justice in the third quarter related to its marketed medicines, seeking documents related primarily to its "good laboratory practices" in a bioanalytical lab. Separately, drugmaker Mylan NV and drugstore chain CVS Health Corp said in their quarterly filings that they had...» Read More
Sept 17- Drugstore chain operator Rite Aid Corp cut its full-year forecast for drugstore sales and total earnings, citing "recent sales trends" and expenses related to its $2 billion acquisition of pharmacy benefit manager EnvisionRx. Rite Aid cut its drugstore sales forecast for the year ending February to $26.7 billion- $27.0 billion from $26.9 billion-...
Sept 17- Drugstore chain operator Rite Aid Corp reported a 17.5 percent rise in quarterly revenue, helped by its $2 billion acquisition of pharmacy benefit manager EnvisionRx. Net income fell to $21.5 million, or 2 cents per share, in the second quarter ended Aug. 29, from $127.8 million, or 13 cents per share, a year earlier. Revenue rose to $7.66 billion from $6.52...
CNBC's Jane Wells reports from Arcata, California, where the city council wants to build the country's first marijuana innovation zone.
A new government study on blood pressure found potentially lifesaving results, reports CNBC's Meg Tirrell.
Disappointing clinical results for GSK-Theravance respiratory treatment.
CHICAGO, Sept 3- CVS Health Corp said on Thursday its decision to stop selling tobacco products last year led to a 1 percent decrease in cigarette sales in some states where the drugstore chain has a sizeable presence. The September 2014 decision hurt sales, with general merchandise revenue at CVS pharmacies open at least a year falling 7.8 percent in the second...
Amgen wins FDA approval for cholesterol-lowering drug Repatha.
Abbott denies FT speculation about a St. Jude's acquisition.
Shares of Valeant are down 6 percent after buying Sprout Pharmaceuticals, the maker of the "female Viagra" drug. CNBC's Meg Tirrell discusses drug deals.
Valeant to purchase flibanserin-maker Sprout for $1 billion.
The FDA approved the first prescription drug for enhancing female libido.
Wal-Mart Stores Inc said on Tuesday that lower margins in its pharmacy business had emerged as a drag on profits, as it gets paid less by drug plan managers and as fewer customers pay in cash, since Obamacare has increased the ranks of insured Americans. The company warned that the margin squeeze would continue for at least the remainder of the year, although a...
Aug 18- Wal-Mart Stores Inc reported weaker quarterly earnings and lowered its annual forecast on Tuesday, as it copes with higher labor costs, a squeeze on pharmacy margins and sliding sales at its British supermarket chain. Net profit attributable to Wal-Mart fell to $3.48 billion, or $1.08 per share, in the second quarter ended July 31, from $3.92 billion, or...
Aug 18- Wal-Mart Stores Inc reported weaker-than-expected quarterly earnings and lowered its annual forecast on Tuesday, citing higher costs from adding worker hours as well as weaker margins in its U.S. pharmacy business. Wal-Mart lowered its forecast for the year ending in January to a range of $4.40 to $4.70 from its outlook of $4.70 to $5.05 in February.
Aug 18- Wal-Mart Stores Inc reported weaker-than-expected quarterly earnings and lowered its full-year forecast, citing higher costs from adding worker hours as well as weaker margins in its U.S. pharmacy business. For the year ending in January, Wal-Mart lowered its earnings-per-share forecast to a range of $4.40 to $4.70 from its outlook of $4.70 to $5.05...
Aug 18- Wal-Mart Stores Inc reported weaker-than-expected quarterly earnings and lowered its full-year forecast on Tuesday, citing investments in staffing and weaker margins in its U.S. pharmacy business. Net profit attributable to Wal-Mart fell to $1.08 per share, in the second quarter ended July 31 from $1.21 per share, a year earlier.
Don Weatherhold, Aprecia Pharmaceuticals CEO, discusses Aprecia and the technology of 3-D printing and prescription drugs.
The drugstore is expanding to accept Apple Pay and Google Wallet Saturday after slashing support last year. Re/code reports.
Rite Aid to start accepting mobile payments this Saturday.
CVS says Pfizer's Viagra will no longer be an approved formula in 2016, reports CNBC's Bertha Coombs.